SCYX
SCYNEXIS, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$5.30
−0.84%Margins
Gross margin
100.0%
EBITDA margin
-53.3%
EBIT margin
-117.6%
Net margin
-53.3%
FCF margin
-69.3%
-15.3%
Return on equity
-13.7%
Return on assets
-32.8%
Return on invested capital
0.25x
Asset turnover
-$13.3M
Cash from operations
$5.44
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026